Exploration of effective biomarkers and infiltrating Immune cells in Osteoarthritis based on bioinformatics analysis
Source abstract
Abstract
Osteoarthritis (OA) is a multi-factorial chronic joint disease mainly identified by synovial inflammation, cartilage damage, and degeneration. Our study applied bioinformatics analysis to uncover the immunity in OA and tried to explore the underlying immune-related molecular mechanism. First, OA-related gene-expression profiling data were retrieved from GEO database. Then, we analysed a series of datadata with using the xCell algorithm, GEO2R, enrichment analysis of SangerBox website, CytoHubba, ROC logistic regression and correlation analysis. Finally, Nine infiltrating immune cells with differential abundance between OA and normal samples were obtained. There were 42 IODEGs in OA, and their functions were associated with immune cells and corresponding biological processes. Moreover, 5 hub genes, including GREM1, NRP1, VEGFA, FYN and IL6R, were identified. Correlation analysis demonstrated that NRP1 was negatively associated with NKT cells, NRP1 and GREM1 were positively associated with aDC, VEGFA was positively associated with CD8+ naïve T cells, while VEGFA, FYN and IL6R were negatively associated with Macrophages M1. The 5 hub genes could be employed as effective diagnostic biomarkers for OA. In addition, they may participate in OA pathogenesis via interactions with infiltrating immune cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Inflammatory mediators and NSAID effects · Cytokine Signaling Pathways and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Orthopedics, Affiliated Hospital of Zunyi Medical University, Zunyi, China
Key Laboratory of Cell Engineering of Guizhou Province, Affiliated Hospital of Zunyi Medical University, Zunyi, China
Joint Orthopaedic Research Center, Zunyi Medical University & University of Rochester Medical Center, Zunyi, China
Funding
National Natural Science Foundation of China
References (65)
Show source-provided references
1. 10.1001/jama.2020.2217110.1001/jama.2020.22171 ↗
2. 10.1016/S0140-6736(18)32279-710.1016/S0140-6736(18)32279-7 ↗
3. Vincent TL. · Curr Opin Pharmacol · 2013 · 13 · 44910.1016/j.coph.2013.01.010 ↗
4. 10.1016/j.bone.2012.02.01210.1016/j.bone.2012.02.012 ↗
5. 10.1002/jor.2445710.1002/jor.24457 ↗
6. 10.1016/j.joca.2020.01.00710.1016/j.joca.2020.01.007 ↗
7. 10.1016/j.actbio.2021.12.00610.1016/j.actbio.2021.12.006 ↗
8. Nedunchezhiyan U · Front Immunol · 2022 · 13 · 90775010.3389/fimmu.2022.907750 ↗
9. 10.3390/ijms2217920810.3390/ijms22179208 ↗
10. Wu ZY · J Orthop Surg Res · 2021 · 16 · 63010.1186/s13018-021-02796-6 ↗
11. 10.1186/s13059-017-1349-110.1186/s13059-017-1349-1 ↗
12. Attur M · Arthritis Res Ther · 2021 · 23 · 10410.1186/s13075-021-02477-z ↗
13. 10.1186/ar452610.1186/ar4526 ↗
14. 10.1038/sdata.2018.1510.1038/sdata.2018.15 ↗
15. 10.1093/bioinformatics/btm25410.1093/bioinformatics/btm254 ↗
16. 10.1093/nar/gkv00710.1093/nar/gkv007 ↗
17. 10.1093/bioinformatics/btq17010.1093/bioinformatics/btq170 ↗
18. 10.1093/nar/28.1.2710.1093/nar/28.1.27 ↗
19. 10.1002/imt2.3610.1002/imt2.36 ↗
20. 10.1101/gr.123930310.1101/gr.1239303 ↗
21. 10.1109/TVCG.2014.234624810.1109/TVCG.2014.2346248 ↗
22. 10.1038/psp.2013.5610.1038/psp.2013.56 ↗
23. Kulkarni P · Adv Clin Chem · 2021 · 100 · 3710.1016/bs.acc.2020.04.002 ↗
24. Lin R · Theranostics · 2019 · 9 · 630010.7150/thno.36120 ↗
25. 10.1016/j.joca.2019.10.01010.1016/j.joca.2019.10.010 ↗
26. Deng Z · Int Immunopharmacol · 2021 · 101 · 10817910.1016/j.intimp.2021.108179 ↗
27. 10.1038/s41586-019-1471-110.1038/s41586-019-1471-1 ↗
28. Manferdini C · Arthritis Res Ther · 2016 · 18 · 8310.1186/s13075-016-0983-4 ↗
29. Wood MJ · JCI Insight · 2019 · 4 · 12532510.1172/jci.insight.125325 ↗
30. Lv Z · Cell Death Dis · 2021 · 12 · 50410.1038/s41419-021-03792-8 ↗
31. 10.1038/s41419-021-03800-x10.1038/s41419-021-03800-x ↗
32. Lu J · Arthritis Res Ther · 2021 · 23 · 14210.1186/s13075-021-02512-z ↗
33. 10.1002/art.4148610.1002/art.41486 ↗
34. Rosshirt N · Arthritis Res Ther · 2021 · 23 · 3710.1186/s13075-020-02410-w ↗
35. Li YS · Front Immunol · 2017 · 8 · 356
36. 10.1002/jor.2499810.1002/jor.24998 ↗
37. 10.1093/rheumatology/keaa74510.1093/rheumatology/keaa745 ↗
38. Tardif G · Arthritis Rheum · 2004 · 50 · 252110.1002/art.20441 ↗
39. 10.1016/j.joca.2008.06.02210.1016/j.joca.2008.06.022 ↗
40. Huang X · Cartilage · 2021 · 12 · 49610.1177/1947603519841676 ↗
41. Yi J · Med Sci Monit · 2016 · 22 · 406210.12659/MSM.897849 ↗
42. 10.1016/j.clim.2021.10888910.1016/j.clim.2021.108889 ↗
43. Lepelletier Y · Eur J Immunol · 2006 · 36 · 178210.1002/eji.200535601 ↗
44. 10.1002/art.3048210.1002/art.30482 ↗
45. Sumi C · Mediators Inflamm · 2018 · 2018 · 110.1155/2018/5703651 ↗
46. 10.1002/jcb.2647010.1002/jcb.26470 ↗
47. 10.3390/ijms1907201210.3390/ijms19072012 ↗
48. 10.1016/S0925-4773(01)00601-310.1016/S0925-4773(01)00601-3 ↗
49. Midy V · Biochem Biophys Res Commun · 1994 · 199 · 38010.1006/bbrc.1994.1240 ↗
50. 10.1242/dev.0105310.1242/dev.01053 ↗
51. 10.1016/j.bone.2021.11603410.1016/j.bone.2021.116034 ↗
52. Cao F · Int Immunopharmacol · 2021 · 96 · 10778610.1016/j.intimp.2021.107786 ↗
53. 10.1016/j.joca.2021.07.00310.1016/j.joca.2021.07.003 ↗
54. Li K · Ann Rheum Dis · 2018 · 77 · 935
55. Sui C · Mol Med Rep · 2019 · 20 · 2633
56. 10.2217/rme-2021-016910.2217/rme-2021-0169 ↗
57. 10.1038/s41388-020-01562-y10.1038/s41388-020-01562-y ↗
58. Xuan Y · Front Pharmacol · 2022 · 13 · 86261810.3389/fphar.2022.862618 ↗
59. 10.1080/08916934.2022.203712910.1080/08916934.2022.2037129 ↗
60. 10.1161/CIRCULATIONAHA.118.03416510.1161/CIRCULATIONAHA.118.034165 ↗
61. Dong D · Faseb j · 2022 · 36 · e2226110.1096/fj.202101567R ↗
62. 10.1186/s12943-019-0988-010.1186/s12943-019-0988-0 ↗
63. Oussa NA · J Immunol · 2016 · 197 · 392710.4049/jimmunol.1601116 ↗
64. 10.1016/j.immuni.2008.01.01210.1016/j.immuni.2008.01.012 ↗
65. Stradner MH · Immunol Cell Biol · 2016 · 94 · 64010.1038/icb.2016.19 ↗